Cell transplant for advanced parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have had Parkinson's disease for at least 5 years.
- Your current Parkinson's medications do not control your symptoms well enough.
- You have a significant response to levodopa (at least 30% improvement).
- You are able to follow the study procedures and give informed consent.
- You do not have other major health problems that could affect the safety of the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.
This trial tests a new stem cell treatment called NouvNeu001 for people with early-onset Parkinson's disease. The goal is to see if it's safe and if it can help improve movement and daily life.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Hear when a new PD - Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.